(Q54388835)

English

The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Vladimir Jurisic

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Marina Petrović

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Zoran Bukumirić

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Vladimir Zdravković

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Slobodanka Mitrović

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Henry Dushan Atkinson

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

30 December 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Medical Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

823

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375395%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

https://scigraph.springernature.com/pub.10.1007/s12032-013-0823-1

0 references

Multidisciplinary management of lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Could we expect to improve survival in small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Current standards of care in small-cell and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Small cell lung cancer: state of the art and future perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Recent advances with topotecan in the treatment of lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Treatment of extensive-stage small cell lung carcinoma: current status and future prospects

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Is more better? Chemotherapy for patients with extensive-stage small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Survival and prognostic factors in small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

ProGRP: a new biomarker for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

Chromogranin A, a significant prognostic factor in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0823-1

21 January 2018

The diagnostic and prognostic value of ProGRP in lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Pro gastrin-releasing peptide (ProGRP)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54388835&oldid=1420739954"